Molecular Imaging Agents Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : October 2019 Pages : 180 Category: Biotechnology Report Code : HC106282
Molecular Imaging Agents Market By Type (Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, and other ) and Application (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, and others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Molecular Imaging Agents Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Molecular imaging is another biomedical research that empowers the measurement, perception, and portrayal of biologic procedures occurring at the phone and subcellular levels. Molecular imaging assumes a significant job in finding early appraisal, chance stratification, and line up of patients with neurological infections. Molecular imaging offers extraordinary dreams that aid in the assessment and the executives of cardiovascular ailment conditions like cardiovascular breakdown, ischemic damage and left ventricular rebuilding, thrombosis, and angiogenesis. Sub-atomic imaging is a field that depends on the accessibility of significant biomarkers and the upgrades in recognition advances. The fundamental utilization of sub-atomic imaging is the examination of biologic procedures of a living subject cell so as to recognize their sub-atomic variations from the norm that structure the starting point of infection.
Drivers and Restraints
Molecular imaging operator ought to have the accompanying qualities: high selectivity for the biochemical objective, great in vivo solidness, cost and time viable amalgamation, great proportion of explicit to vague authoritative, signal enhancement, great security profile, and multiplexing abilities. Expanding maturing populace experiencing end organize infection and rising commonness of malignant growth issues are relied upon to drive the interest for sub-atomic imaging. The requirement for digitization, costly venture and novel complexity specialists are likewise driving the atomic imaging operators to advertise. The worldwide atomic imaging specialists market is probably going to be limited by the market solidification. The quick pace of development limits spending and the absence of mindfulness are some controls to worldwide atomic imaging specialists showcase.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- General Electric
- Bracco Diagnostic
- Eisai
- Guerbet
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Molecular Imaging Agents Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Small Molecules
o Peptide
o Engineered Protein Fragments
o Aptamers
o Nanoparticles
o Other
· Molecular Imaging Agents Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Oncology
o Cardiology
o Gastrointestinal Disorders
o Neurology Disorders
o Others
· Molecular Imaging Agents Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o General Electric
o Bracco Diagnostic
o Eisai
o Guerbet
· Molecular Imaging Agents Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Molecular Imaging Agents Market, By Type
5.1. Introduction
5.2. Global Molecular Imaging Agents Revenue and Market Share by Type (2017-2027)
5.2.1. Global Molecular Imaging Agents Revenue and Revenue Share by Type (2017-2027)
5.3. Small Molecules
5.3.1. Global Small Molecules Revenue and Growth Rate (2017-2027)
5.4. Peptide
5.4.1. Global Peptide Revenue and Growth Rate (2017-2027)
5.5. Engineered Protein Fragments
5.5.1. Global Engineered Protein Fragments Revenue and Growth Rate (2017-2027)
5.6. Aptamers
5.6.1. Global Aptamers Revenue and Growth Rate (2017-2027)
5.7. Nanoparticles
5.7.1. Global Nanoparticles Revenue and Growth Rate (2017-2027)
5.8. Other
5.8.1. Global Other Revenue and Growth Rate (2017-2027)
6. Molecular Imaging Agents Market, By Application
6.1. Introduction
6.2. Global Molecular Imaging Agents Revenue and Market Share by Application (2017-2027)
6.2.1. Global Molecular Imaging Agents Revenue and Revenue Share by Application (2017-2027)
6.3. Oncology
6.3.1. Global Oncology Revenue and Growth Rate (2017-2027)
6.4. Cardiology
6.4.1. Global Cardiology Revenue and Growth Rate (2017-2027)
6.5. Gastrointestinal Disorders
6.5.1. Global Gastrointestinal Disorders Revenue and Growth Rate (2017-2027)
6.6. Neurology Disorders
6.6.1. Global Neurology Disorders Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Molecular Imaging Agents Market, By Region
7.1. Introduction
7.2. Global Molecular Imaging Agents Revenue and Market Share by Regions
7.2.1. Global Molecular Imaging Agents Revenue by Regions (2017-2027)
7.3. North America Molecular Imaging Agents by Countries
7.3.1. North America Molecular Imaging Agents Revenue and Growth Rate (2017-2027)
7.3.2. North America Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Molecular Imaging Agents by Countries
7.4.1. Europe Molecular Imaging Agents Revenue and Growth Rate (2017-2027)
7.4.2. Europe Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Molecular Imaging Agents by Countries
7.5.1. Asia-Pacific Molecular Imaging Agents Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Molecular Imaging Agents by Countries
7.6.1. South America Molecular Imaging Agents Revenue and Growth Rate (2017-2027)
7.6.2. South America Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Molecular Imaging Agents by Countries
7.7.1. Middle East and Africa Molecular Imaging Agents Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. General Electric
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Bracco Diagnostic
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Eisai
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Guerbet
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
9. Molecular Imaging Agents Market Forecast (2017-2027)
9.1. Global Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Molecular Imaging Agents Market Forecast by Regions (2017-2027)
9.2.1. North America Molecular Imaging Agents Market Forecast (2017-2027)
9.2.1.1. United States Molecular Imaging Agents Market Forecast (2017-2027)
9.2.1.2. Canada Molecular Imaging Agents Market Forecast (2017-2027)
9.2.1.3. Mexico Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2. Europe Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.1. Germany Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.2. France Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.3. UK Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.4. Russia Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.5. Italy Molecular Imaging Agents Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3. Asia-Pacific Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.1. China Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.2. Japan Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.3. Korea Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.4. India Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Molecular Imaging Agents Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Molecular Imaging Agents Market Forecast (2017-2027)
9.2.4. South America Molecular Imaging Agents Market Forecast (2017-2027)
9.2.4.1. Brazil Molecular Imaging Agents Market Forecast (2017-2027)
9.2.4.2. Argentina Molecular Imaging Agents Market Forecast (2017-2027)
9.2.4.3. Columbia Molecular Imaging Agents Market Forecast (2017-2027)
9.2.4.4. Rest of South America Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5. Middle East and Africa Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.3. Egypt Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.4. Nigeria Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.5. South Africa Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.6. Turkey Molecular Imaging Agents Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Molecular Imaging Agents Market Forecast (2017-2027)
9.3. Molecular Imaging Agents Market Forecast by Type (2017-2027)
9.3.1. Molecular Imaging Agents Forecast by Type (2017-2027)
9.3.2. Molecular Imaging Agents Market Share Forecast by Type (2017-2027)
9.4. Molecular Imaging Agents Market Forecast by Application (2017-2027)
9.4.1. Molecular Imaging Agents Forecast by Application (2017-2027)
9.4.2. Molecular Imaging Agents Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Molecular Imaging Agents Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Molecular Imaging Agents Revenue and Revenue Share by Type (2017-2018)
Figure Global Small Molecules Revenue and Growth Rate (2017-2018)
Figure Global Peptide Revenue and Growth Rate (2017-2018)
Figure Global Engineered Protein Fragments Revenue and Growth Rate (2017-2018)
Figure Global Aptamers Revenue and Growth Rate (2017-2018)
Figure Global Nanoparticles Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Molecular Imaging Agents Revenue and Revenue Share by Application (2017-2018)
Figure Global Oncology Revenue and Growth Rate (2017-2018)
Figure Global Cardiology Revenue and Growth Rate (2017-2018)
Figure Global Gastrointestinal Disorders Revenue and Growth Rate (2017-2018)
Figure Global Neurology Disorders Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Molecular Imaging Agents Revenue by Regions (2017-2018)
Figure North America Molecular Imaging Agents Growth Rate (2017-2018)
Figure North America Molecular Imaging Agents Revenue and Growth Rate (2017-2018)
Figure North America Molecular Imaging Agents by Countries (2017-2018)
Figure North America Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2018)
Figure United States Molecular Imaging Agents Growth Rate (2017-2018)
Figure United States Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Molecular Imaging Agents Growth Rate (2017-2018)
Figure Canada Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Molecular Imaging Agents Growth Rate (2017-2018)
Figure Mexico Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Molecular Imaging Agents Growth Rate (2017-2018)
Figure Europe Molecular Imaging Agents Revenue and Growth Rate (2017-2018)
Figure Europe Molecular Imaging Agents by Countries (2017-2018)
Figure Europe Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2018)
Figure Germany Molecular Imaging Agents Growth Rate (2017-2018)
Figure Germany Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Molecular Imaging Agents Growth Rate (2017-2018)
Figure France Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Molecular Imaging Agents Growth Rate (2017-2018)
Figure UK Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Molecular Imaging Agents Growth Rate (2017-2018)
Figure Russia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Molecular Imaging Agents Growth Rate (2017-2018)
Figure Italy Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Molecular Imaging Agents Growth Rate (2017-2018)
Figure Rest of Europe Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Molecular Imaging Agents Growth Rate (2017-2018)
Figure Asia-Pacific Molecular Imaging Agents Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Molecular Imaging Agents by Countries (2017-2018)
Figure Asia-Pacific Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2018)
Figure China Molecular Imaging Agents Growth Rate (2017-2018)
Figure China Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Molecular Imaging Agents Growth Rate (2017-2018)
Figure Japan Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Molecular Imaging Agents Growth Rate (2017-2018)
Figure Korea Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Molecular Imaging Agents Growth Rate (2017-2018)
Figure India Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Molecular Imaging Agents Growth Rate (2017-2018)
Figure Southeast Asia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Molecular Imaging Agents Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Molecular Imaging Agents Growth Rate (2017-2018)
Figure South America Molecular Imaging Agents Revenue and Growth Rate (2017-2018)
Figure South America Molecular Imaging Agents by Countries (2017-2018)
Figure South America Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Molecular Imaging Agents Growth Rate (2017-2018)
Figure Brazil Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Molecular Imaging Agents Growth Rate (2017-2018)
Figure Argentina Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Molecular Imaging Agents Growth Rate (2017-2018)
Figure Columbia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Molecular Imaging Agents Growth Rate (2017-2018)
Figure Rest of South America Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Molecular Imaging Agents Growth Rate (2017-2018)
Figure Middle East and Africa Molecular Imaging Agents Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Molecular Imaging Agents by Countries (2017-2018)
Figure Middle East and Africa Molecular Imaging Agents Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Molecular Imaging Agents Growth Rate (2017-2018)
Figure Saudi Arabia Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Molecular Imaging Agents Growth Rate (2017-2018)
Figure United Arab Emirates Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Molecular Imaging Agents Growth Rate (2017-2018)
Figure Egypt Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Molecular Imaging Agents Growth Rate (2017-2018)
Figure Nigeria Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Molecular Imaging Agents Growth Rate (2017-2018)
Figure South Africa Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Molecular Imaging Agents Growth Rate (2017-2018)
Figure Turkey Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Molecular Imaging Agents Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2017-2018)
Table General Electric Molecular Imaging Agents Financial Overview
Table Bracco Diagnostic Molecular Imaging Agents Financial Overview
Table Eisai Molecular Imaging Agents Financial Overview
Table Guerbet Molecular Imaging Agents Financial Overview
Figure Global Molecular Imaging Agents Revenue (Millions USD) and Growth Rate (2018-2025)
Table Molecular Imaging Agents Market Forecast by Regions (2018-2025)
Figure North America Molecular Imaging Agents Market Forecast (2018-2025)
Figure United States Molecular Imaging Agents Market Forecast (2018-2025)
Figure Canada Molecular Imaging Agents Market Forecast (2018-2025)
Figure Mexico Molecular Imaging Agents Market Forecast (2018-2025)
Figure Europe Molecular Imaging Agents Market Forecast (2018-2025)
Figure Germany Molecular Imaging Agents Market Forecast (2018-2025)
Figure France Molecular Imaging Agents Market Forecast (2018-2025)
Figure UK Molecular Imaging Agents Market Forecast (2018-2025)
Figure Russia Molecular Imaging Agents Market Forecast (2018-2025)
Figure Italy Molecular Imaging Agents Market Forecast (2018-2025)
Figure Rest of Europe Molecular Imaging Agents Market Forecast (2018-2025)
Figure Asia-Pacific Molecular Imaging Agents Market Forecast (2018-2025)
Figure China Molecular Imaging Agents Market Forecast (2018-2025)
Figure Japan Molecular Imaging Agents Market Forecast (2018-2025)
Figure Korea Molecular Imaging Agents Market Forecast (2018-2025)
Figure India Molecular Imaging Agents Market Forecast (2018-2025)
Figure Southeast Asia Molecular Imaging Agents Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Molecular Imaging Agents Market Forecast (2018-2025)
Figure South America Molecular Imaging Agents Market Forecast (2018-2025)
Figure Brazil Molecular Imaging Agents Market Forecast (2018-2025)
Figure Argentina Molecular Imaging Agents Market Forecast (2018-2025)
Figure Columbia Molecular Imaging Agents Market Forecast (2018-2025)
Figure Rest of South America Molecular Imaging Agents Market Forecast (2018-2025)
Figure Middle East and Africa Molecular Imaging Agents Market Forecast (2018-2025)
Figure Saudi Arabia Molecular Imaging Agents Market Forecast (2018-2025)
Figure United Arab Emirates Molecular Imaging Agents Market Forecast (2018-2025)
Figure Egypt Molecular Imaging Agents Market Forecast (2018-2025)
Figure Nigeria Molecular Imaging Agents Market Forecast (2018-2025)
Figure South Africa Molecular Imaging Agents Market Forecast (2018-2025)
Figure Turkey Molecular Imaging Agents Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Molecular Imaging Agents Market Forecast (2018-2025)
Figure Global Molecular Imaging Agents Forecast by Type (2018-2025)
Figure Global Molecular Imaging Agents Market Share Forecast by Type (2018-2025)
Figure Global Molecular Imaging Agents Forecast by Type (2018-2025)
Figure Global Molecular Imaging Agents Forecast by Application (2018-2025)
Figure Global Molecular Imaging Agents Market Share Forecast by Application (2018-2025)
Figure Global Molecular Imaging Agents Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|